Showing results (371-380 of 448) with videos related to

Sort By:
Pageof 45
Pediatrics|February 17, 2005
Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 monthsNamasivayam Ambalavanan, Jon E Tyson, Kathleen A Kennedy, et al.
Bone Marrow Transplantation|June 30, 2015
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trialP Gimsing, Ø Hjertner, N Abildgaard, et al.
Pediatrics|November 7, 2007
Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomesRachel V Walden, Sarah C Taylor, Nellie I Hansen, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2024
Clinico-pathological characteristics and treatment outcome in non-small cell lung cancer in Greenland 2015-2020 - a comparison with the cohort from 2004 to 2010Dorte S Nørøxe, Simone Frandsen, Malene M Clausen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Extensive inflammatory pseudotumor of the pituitaryI Hansen, P Petrossians, A Thiry, et al.
Frontiers in Human Neuroscience|March 12, 2024
A method for synchronized use of EEG and eye tracking in fully immersive VROlav F P Larsen, William G Tresselt, Emanuel A Lorenz, et al.
Pediatrics|January 2, 2009
Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infantsC Michael Cotten, Sarah Taylor, Barbara Stoll, et al.
Diabetologia|March 11, 2017
Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetesTor I Hansen, Sandra E Olsen, Elise C D Haferstrom, et al.
Cell Cycle (Georgetown, Tex.)|March 4, 2011
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell linesGiuditta Viticchiè, Anna Maria Lena, Alessia Latina, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
Pageof 45